SCHEMBL8574206

SCHEMBL8574206

CC1Oc2ccccc2C(=O)N1CCOc1ccccc1C=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ RAD52 P43351 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796640 0.83 RAB9A (0.44) HPGDALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL9174733 0.76 ALDH1A1 (0.40) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL9303669 0.76 CA2 (0.35) ALDH1A1SMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL8575194 0.75 KMT2A (0.55) HPGDALDH1A1HTTSMN1; SMN2KMT2A
SCHEMBL9175683 0.75 RAB9A (0.34) ALDH1A1KMT2ARAB9ANPC1MAOB
SCHEMBL8576743 0.74 ALDH1A1 (0.46) HPGDALDH1A1HTTSMN1; SMN2KMT2A
SCHEMBL9172583 0.74 PARP1 (0.43) HTTKMT2AMEN1RAB9ANPC1
SCHEMBL8576377 0.74 KDM4E (0.40) ALDH1A1KMT2ARAB9ANPC1TSHR
SCHEMBL8577745 0.71 KMT2A (0.48) HPGDALDH1A1HTTSMN1; SMN2KMT2A
SCHEMBL8797385 0.71 MGAM (0.55) HPGDMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5710152-A ANTIDIABETIC, ANTILIPEMIC, AND HYPOGLYCEMIC AGENTS; DIETETICS SS PHARMACEUTICAL CO., LTD. (JP) 1998-01-20 — — US disclosed
Send feedback